ADDvise Group Future Growth

Future criteria checks 2/6

ADDvise Group is forecast to grow earnings and revenue by 15.4% and 9.5% per annum respectively. EPS is expected to grow by 14.5% per annum. Return on equity is forecast to be 17.3% in 3 years.

Key information

15.4%

Earnings growth rate

14.5%

EPS growth rate

Medical Equipment earnings growth	16.2%
Revenue growth rate	9.5%
Future return on equity	17.3%
Analyst coverage	Low
Last updated	22 Jul 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:Q3I - Analysts future estimates and past financials data (SEK Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	1,927	193	246	287	2
12/31/2025	1,810	161	202	254	2
12/31/2024	1,723	136	202	263	2
6/30/2024	1,550	138	70	98	N/A
3/31/2024	1,483	111	86	106	N/A
12/31/2023	1,379	104	157	175	N/A
9/30/2023	1,302	102	208	225	N/A
6/30/2023	1,218	101	189	202	N/A
3/31/2023	1,105	117	211	226	N/A
12/31/2022	959	81	96	110	N/A
9/30/2022	793	55	66	35	N/A
6/30/2022	660	19	34	18	N/A
3/31/2022	545	0	-4	-2	N/A
12/31/2021	469	3	6	10	N/A
9/30/2021	410	7	-32	9	N/A
6/30/2021	380	11	-4	20	N/A
3/31/2021	364	20	42	47	N/A
12/31/2020	359	15	56	57	N/A
9/30/2020	365	17	42	47	N/A
6/30/2020	369	12	33	38	N/A
3/31/2020	360	2	12	17	N/A
12/31/2019	354	4	5	11	N/A
9/30/2019	325	0	-4	0	N/A
6/30/2019	306	-2	1	2	N/A
3/31/2019	280	-1	-3	3	N/A
12/31/2018	271	-1	-5	0	N/A
9/30/2018	260	-7	-19	-13	N/A
6/30/2018	248	-7	-25	-16	N/A
3/31/2018	250	-5	N/A	-17	N/A
12/31/2017	244	-6	N/A	-19	N/A
9/30/2017	235	-3	N/A	-19	N/A
6/30/2017	229	1	N/A	-27	N/A
3/31/2017	214	6	N/A	-35	N/A
12/31/2016	198	0	N/A	-32	N/A
9/30/2016	183	-6	N/A	-25	N/A
6/30/2016	173	-13	N/A	-13	N/A
3/31/2016	156	-18	N/A	-15	N/A
12/31/2015	151	-11	N/A	-4	N/A
9/30/2015	160	-8	N/A	-7	N/A
6/30/2015	154	-4	N/A	-6	N/A
3/31/2015	151	-4	N/A	5	N/A
12/31/2014	144	-5	N/A	-9	N/A
9/30/2014	138	-6	N/A	-9	N/A
6/30/2014	137	-4	N/A	4	N/A
3/31/2014	133	-3	N/A	6	N/A
12/31/2013	125	-4	N/A	-6	N/A
9/30/2013	120	0	N/A	9	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Q3I's forecast earnings growth (15.4% per year) is above the savings rate (0.8%).

Earnings vs Market: Q3I's earnings (15.4% per year) are forecast to grow slower than the German market (20% per year).

High Growth Earnings: Q3I's earnings are forecast to grow, but not significantly.

Revenue vs Market: Q3I's revenue (9.5% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: Q3I's revenue (9.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Q3I's Return on Equity is forecast to be low in 3 years time (17.3%).

ADDvise Group Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

ADDvise Group AB (publ) Provides Earnings Guidance for the Year 2023

Recent updates

ADDvise Group AB (publ) Announces Chief Financial Officer Changes

Addvise Group AB (Publ) Announces Chief Executive Officer Changes

ADDvise Group AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 100 million.

Addvise Group AB (Publ) Announces Erland Pontusson Decline Re-Election from the Board

ADDvise Group AB (publ) (OM:ADDV A) acquired Axelerist, Inc. for $29.4 million.

ADDvise Group AB (publ) to Report First Half, 2024 Results on Jul 18, 2024

ADDvise Group AB (publ) (OM : ADDV A) completed the acquisition of Diabetic Supply Inc.

ADDvise Group AB (publ) Announces Management Changes

Addvise Group AB (Publ) Appoints Oliver Humlen as Member of the Executive Management Team

ADDvise Group AB (publ) Provides Earnings Guidance for the Year 2023

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Innovative Endoscopy Components, L.L.C. for $11.75? million.

ADDvise Group AB (publ) (OM:ADDV A) has signed a Letter of Intent to acquire Kolplast CI S.A. for approximately BRL 210 million.

ADDvise Group AB (publ) (OM:ADDV A) signed a letter of intent to acquire X-Ray Cassette Repair Company, Inc. for approximately $15 million.

ADDvise Group Appoints Fredrik Mella as Senior Vice President Alongside His Current Role as Chief Operating Officer

ADDvise Group AB (publ) to Report Fiscal Year 2022 Final Results on Apr 05, 2023

ADDvise Group AB (publ), Annual General Meeting, May 05, 2023

ADDvise Group AB (publ) (OM:ADDV A) entered into a letter of intent to acquire Clinichain Holding B.V. for €33.80 million.

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Seebreath AB from the shareholders.

ADDvise Group AB (publ) Announces Executive Changes

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Surplus Diabetic, Inc for $19.5 million.

Addvise Group AB (Publ) Not to Propose Any Dividend for the Financial Year 2021

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies